ENTITYORGResearch Activity Zephyrm Seeks Hong Kong IPO to Fund Phase III Cell Therapy Trials 7 months ago talkbio0Tagged Cell Therapy, IPO, Kong listing, Phase 3 Clinical Trials, Zephyrm Zephyrm, IPO, cell therapy, Phase III trials, Hong Kong listing Read More